When is the best time to perform upper digestive endoscopy to detect the presence of esophageal varices in patients with cirrhosis?;¿Cuándo sería más rentable realizar una endoscopia digestiva alta para establecer la presencia de varices esofágicas en pacientes con cirrosis?

Gastroenterologia y Hepatologia

Volumn 27, Issue 6, 2004, Pages 353-356

  Adrover, R ^a,b   Cocozzella, D ^a   Borzi, S ^a   Montenegro, L ^a   Defelitto, M ^a   Bosia, D ^a   Fraquelli, E ^a   Curciarello, J ^a  

^a Hospital Interzonal General de Agudos de La Plata   (Argentina)

^b NONE   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; B SCAN; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; ENDOSCOPY; ESOPHAGUS VARICES; ESOPHAGUS VARICES BLEEDING; FEMALE; HEALTH CARE COST; HEPATITIS C VIRUS; HUMAN; LIVER CIRRHOSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTPATIENT CARE; SPLEEN SIZE; THROMBOCYTE COUNT; COMPARATIVE STUDY; GASTROINTESTINAL ENDOSCOPY; HOSPITALIZATION; LIVER FUNCTION TEST; MIDDLE AGED; RISK FACTOR; TIME;

ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 3142780089     PISSN: 02105705     EISSN: None     Source Type: Journal    
DOI: 10.1157/13062889     Document Type: Article

References (24)

1. Peck-Radosavljevic M, Zachrl J, Meng G, et al. Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver? J Hepatol 1997;27:127-31.
2. Adinolfi LE, Giordano MG, Andreana A, et al. Hepatic fibrosis plays a central rol in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis. Br J Haematol 2001;113: 590-5.
3. Gores GJ, Wiesner RH, Dickson ER, et al. Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history, and influence on survival. Gastroenterology 1989;96:1552-9.
4. Groszmann RJ, Bosch J, Grace ND, et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990;99:1401-7.
5. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices: a prospective multicenter study. N Engl J Med 1988;319: 983-9.
6. De Franchis R, Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis 2001;5:645-63.
7. Burroughs AK, McCormick PA. Natural history and prognosis of variceal bleeding. Baillieres Clin Gastroenterol 1992;2:437-50.
8. Gralnek IM, Jensen DM, Kovacs TOG, et al. The economic impact of esophageal variceal hemorrhage: cost-effectiveness implications of endoscopic therapy. Hepatology 1999;29:44-50.
9. Cello JP, Grendell JH, Crass RA, et al. Endoscopic scleropathy versus portocaval shunt in patients with severe cirrhosis and acute variceal hemorrhage: long-term follow-up. N Engl J Med 1987;316:11-5.
10. Wysocki A, Pozniczek M, Budzynski A. Determination of blood cell count and spleen size in patients with liver cirrhosis submitted to endoscopic sclerotherapy for esophageal varices. Prze GI Lek 1999;56:653-5.
11. Schepis F, Camma C, Niceforo D, et al. Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? Hepatology 2001;33:333-8.
12. Ng FH, Wong SY, Loo CK. Prediction of oesophagogastric varices in patients with liver cirrhosis. J Gastroenterol Hepatol 1999; 14:785-90.
13. Zaman A, Hapke R, Flora K, et al. Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease. Am J Gastrenterol 1999;94:3292-6.
14. Madhotra R, Mulcahy HE, Willner I, Reuben A. Prediction of esophageal varices in patients with cirrhosis. J Clin Gastroenterol 2002;34:81-5.
15. Oberti F, Valsesia E, Pilette C, et al. Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology 1997;113:1609-16.
16. Pietri H, Boscaini M. Determination of a splenic volumetric index by ultrasonic scanning. Ultrasound 1984;3:19-23.
17. Japanese Research Society for Portal Hypertension. The general rules for recording endoscopic findings on esophageal varices. Jpn J Surg 1980;10:84.
18. Beppu LA, Inokuchi K, Koyanagi N, et al. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 1981;27:213-8.
19. Grace ND, Groszman RJ, García-Tsao G, et al. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology 1998;28:868-80.
20. De Francis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000;33:846-52.
21. Watanabe S, Hosomi N, Kitade Y, et al. Assessment of the presence and severity of esophagogastric varices by splenic index in patients with liver cirrrhosis. J Comut Assist Tomogr 2000; 24:788-94.
22. Zaman A, Becker T, Lapidus J, Benner K. Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage. Arch Intern Med 2001;161:2564-70.
23. Zoli M, Merkel C, Magalotti D, et al. Natural history of cirrhotic patients with small esophageal varices: a prospective study. Am J Gastroenterol 2000;95:503-8.
24. Cales P, Zabotto C, Meskens C, et al. Gastroesophageal endocopic features in cirrhosis: observer variability, interassociations and hepatic dysfunction. Gastroenterology 1990;98:156-62.